Cargando…
Metabolic Modifications, Inflammation, and Cancer Immunotherapy
Cancer immunotherapy has accomplished significant progresses on treatment of various cancers in the past decade; however, recent studies revealed more and more heterogeneity in tumor microenvironment which cause unneglectable therapy resistance. A central phenomenon in tumor malignancy is metabolic...
Autores principales: | Zheng, Sihao, Song, Qibin, Zhang, Pingfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497755/ https://www.ncbi.nlm.nih.gov/pubmed/34631531 http://dx.doi.org/10.3389/fonc.2021.703681 |
Ejemplares similares
-
Fantastic voyage: The journey of NLRP3 inflammasome activation
por: Que, Xiangyong, et al.
Publicado: (2023) -
Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma
por: Xu, Yiwei, et al.
Publicado: (2023) -
Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy
por: Le Bourgeois, Thibault, et al.
Publicado: (2018) -
Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
por: Decock, Julie, et al.
Publicado: (2023) -
The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy
por: Shriwas, Omprakash, et al.
Publicado: (2021)